Genlong Zhong

Dr. Genlong Zhong

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in Stroke
Verified
Journal Article
Open access
HZHuan Zhou
Huan Zhou
WZWansi Zhong
Wansi Zhong
TZTingxia Zhang
Tingxia Zhang
CXChenghua Xu
Chenghua Xu
GZGenlong Zhong
Genlong Zhong
OGon behalf of the CASE-II Study Group
on behalf of the CASE-II Study Group
BACKGROUND: Current evidence provides limited support for the superiority of endovascular thrombectomy (EVT) in patients with M2 segment middle cerebral artery occlusion. We aim to investigate whether imaging features of M2 segment occlusion impact the effectiveness of EVT. METHODS: We conducted a retrospective cohort study from January 2017 to January 2022, drawing data from the CASE II registry (Computer-Based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation), which specifically documented patients with acute ischemic stroke presenting with M2 segment occlusion undergoing reperfusion therapy. Patients were stratified into the intravenous thrombolysis (IVT) group (IVT alone) and EVT group (IVT plus EVT or EVT alone). The primary outcome was a modified Rankin Scale score 0 to 2 at 90 days. Secondary outcomes included additional thresholds and distribution of modified Rankin Scale scores, 24-hour recanalization, early neurological deterioration, and relevant complications during hospitalization. Safety outcomes encompassed intracranial hemorrhagic events at 24 hours and mortality at 90 days. Binary logistic regression analyses with propensity score matching were used. Subgroup analyses were performed based on the anatomic site of occlusion, including right versus left, proximal versus distal, dominant/co-dominant versus nondominant, single versus double/triple branch(es), and anterior versus central/posterior branch. RESULTS: Among 734 patients (43.3% were females; median age, 73 years) with M2 segment occlusion, 342 (46.6%) were in the EVT group. Propensity score matching analysis revealed no statistical difference in the primary outcome (odds ratio, 0.860 [95% CI, 0.611–1.209]; P =0.385) between the EVT group and IVT group. However, EVT was associated with a higher incidence of subarachnoid hemorrhage (odds ratio, 6.655 [95% CI, 1.487–29.788]; P =0.004) and pneumonia (odds ratio, 2.015 [95% CI, 1.364–2.977]; P <0.001). Subgroup analyses indicated that patients in the IVT group achieved better outcomes when presenting with right, distal, or nondominant branch occlusion ( P all interaction <0.05). CONCLUSIONS: Our study showed similar efficiency of EVT versus IVT alone in acute M2 segment middle cerebral artery occlusion. This suggested that only specific patient subpopulations might have a potentially higher benefit of EVT over IVT alone. REGISTRATION: URL: https://clinicaltrials.gov ; Unique identifier: NCT04487340.

20 July 2023 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
HCHui Cheng
Hui Cheng
HJHaidi Jin
Haidi Jin
YHYongjun Hu
Yongjun Hu
LCLijiang Chen
Lijiang Chen
ZCzhicai chen
zhicai chen
GZGenlong Zhong
Genlong Zhong
Backgrounds: Previous studies have suggested that cerebral dural sinus stenosis could be a possible underlying cause of idiopathic intracranial hypertension (IIH). Venous sinus stenting (VSS) has emerged as a potential alternative for treating IIH related to dural sinus stenosis. However, most of the documented studies have been conducted in Western countries. In this study, we present the results of 16 Chinese IIH patients who underwent VSS treatment in our single center.Methods: We prospectively collected angiographic and manometric data from IIH patients who underwent angioplasty/stenting. All patients had confirmed dural sinus stenosis and had failed maximal medical therapy (MMT). Demographic, clinical, and radiological presentation, as well as long‐term follow‐up outcomes were collected retrospectively.Results: A total of 16 patients who underwent VSS were enrolled in the present study. Demographic data revealed a mean age of 40 (range 20–55), with 69% (11/16) being female, and a mean body mass index (BMI) of 27.05 (range 19.18–38.04) kg/m2. All patients presented with papilledema and visual disturbances. During a median follow‐up period of 47.5 months, 93.75% (15/16) of patients reported improvement in symptoms, although only 37.5% (6/16) experienced complete resolution. Headaches, blurred vision, and amaurosis related to increased pressure improved in 100% (8/8), 81.25% (13/16), and 75% (3/4) of patients, respectively. However, one patient suffered cerebral infarction and secondary epilepsy soon after VSS, and another patient had recurrence of symptoms due to stent wall thrombosis 2 years later.Conclusions: The significance of venous sinus stenosis in the development of IIH may be undervalued. Our study, based on a Chinese case series, affirms the long‐term safety and effectiveness of VSS in treating IIH patients with relatively lower BMI than those from Western countries.

25 July 2017
Verified
Journal Article
Closed access
GZGenlong Zhong
Genlong Zhong
ZCZhicai Chen
Zhicai Chen
RZRuiting Zhang
Ruiting Zhang
CLChang Liu
Chang Liu
YZYing Zhou
Ying Zhou
MLMin Lou
Min Lou